Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
67%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

Active, not recruiting1
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (33.3%)
Phase 42 (66.7%)

Trials by Status

active_not_recruiting133%
completed133%
unknown133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingphase_3

Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults

NCT06798831
unknownphase_4

Optimising the Timing of Whooping Cough Immunisation in MUMs

NCT03908164
completedphase_4

Pertussis and Meningitis C Concomitant Vaccination in Adolescents

NCT02526394

Clinical Trials (3)

Showing 3 of 3 trials
NCT06798831Phase 3

Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults

Active Not Recruiting
NCT03908164Phase 4

Optimising the Timing of Whooping Cough Immunisation in MUMs

Unknown
NCT02526394Phase 4

Pertussis and Meningitis C Concomitant Vaccination in Adolescents

Completed

All 3 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
3